Skip to main content
Top
Published in: Virology Journal 1/2010

Open Access 01-12-2010 | Research

Hepatitis C virus infection in blood donors from the state of Puebla, Mexico

Authors: Francisca Sosa-Jurado, Gerardo Santos-López, Belinda Guzmán-Flores, Julia I Ruiz-Conde, Daniel Meléndez-Mena, Martín T Vargas-Maldonado, Ygnacio Martínez-Laguna, Laura Contreras-Mioni, Verónica Vallejo-Ruiz, Julio Reyes-Leyva

Published in: Virology Journal | Issue 1/2010

Login to get access

Abstract

Background

Worldwide, 130 million persons are estimated to be infected with HCV. Puebla is the Mexican state with the highest mortality due to hepatic cirrhosis. Therefore, it is imperative to obtain epidemiological data on HCV infection in asymptomatic people of this region. The objective of present study was to analyze the prevalence of antibodies and genotypes of hepatitis C virus (HCV) in blood donors from Puebla, Mexico.

Results

The overall prevalence was 0.84% (515/61553). Distribution by region was: North, 0.86% (54/6270); Southeast, 1.04% (75/7197); Southwest, 0.93% (36/3852); and Central, 0.79% (350/44234). Ninety-six donors were enrolled for detection and genotyping of virus, from which 37 (38.5%) were HCV-RNA positive. Detected subtypes were: 1a (40.5%), 1b (27.0%), mixed 1a/1b (18.9%), undetermined genotype 1 (5.4%), 2a (2.7%), 2b (2.7%), and mixed 1a/2a (2.7%). All recovered donors with S/CO > 39 were HCV-RNA positive (11/11) and presented elevated ALT; in donors with S/CO < 39 HCV-RNA, positivity was of 30.4%; and 70% had normal values of ALT. The main risk factors associated with HCV infection were blood transfusion and surgery.

Conclusions

HCV prevalence of donors in Puebla is similar to other Mexican states. The most prevalent genotype is 1, of which subtype 1a is the most frequent.
Appendix
Available only for authorised users
Literature
1.
go back to reference Anonymous: Global burden of disease (GBD) for hepatitis C. J Clin Pharmacol 2004, 44: 20-29. 10.1177/0091270003258669CrossRef Anonymous: Global burden of disease (GBD) for hepatitis C. J Clin Pharmacol 2004, 44: 20-29. 10.1177/0091270003258669CrossRef
2.
go back to reference Shepard CW, Finelli L, Alter MJ: Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005, 5: 558-567. 10.1016/S1473-3099(05)70216-4PubMedCrossRef Shepard CW, Finelli L, Alter MJ: Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005, 5: 558-567. 10.1016/S1473-3099(05)70216-4PubMedCrossRef
3.
go back to reference Lavanchy D: The global burden of hepatitis C. Liver Int 2009,29(Suppl 1):74-81. 10.1111/j.1478-3231.2008.01934.xPubMedCrossRef Lavanchy D: The global burden of hepatitis C. Liver Int 2009,29(Suppl 1):74-81. 10.1111/j.1478-3231.2008.01934.xPubMedCrossRef
4.
go back to reference Chevaliez S, Pawlotsky JM: Hepatitis C virus serologic and virologic tests and clinical diagnosis of HCV-related liver disease. Int J Med Sci 2006, 3: 35-40.PubMedPubMedCentralCrossRef Chevaliez S, Pawlotsky JM: Hepatitis C virus serologic and virologic tests and clinical diagnosis of HCV-related liver disease. Int J Med Sci 2006, 3: 35-40.PubMedPubMedCentralCrossRef
5.
go back to reference Valdespino JL, Conde-Gonzáles JC, Olaiz FG, Palma O, D K, Sepulveda J: Seroprevalencia de la hepatitis C en adultos de México: ¿un problema de salud pública emergente? Salud Publica Mex 2007, 49: S395-S403.CrossRef Valdespino JL, Conde-Gonzáles JC, Olaiz FG, Palma O, D K, Sepulveda J: Seroprevalencia de la hepatitis C en adultos de México: ¿un problema de salud pública emergente? Salud Publica Mex 2007, 49: S395-S403.CrossRef
6.
go back to reference Santos-Lopez G, Sosa-Jurado F, Vallejo-Ruiz V, Melendez-Mena D, Reyes-Leyva J: Prevalence of hepatitis C virus in the Mexican population: a systematic review. J Infect 2008, 56: 281-290. 10.1016/j.jinf.2008.02.001PubMedCrossRef Santos-Lopez G, Sosa-Jurado F, Vallejo-Ruiz V, Melendez-Mena D, Reyes-Leyva J: Prevalence of hepatitis C virus in the Mexican population: a systematic review. J Infect 2008, 56: 281-290. 10.1016/j.jinf.2008.02.001PubMedCrossRef
7.
go back to reference SSA: Morbilidad y mortalidad por cirrosis hepática. In Salud: México 2006. México, D.F.: Secretaría de Salud; 2007:46-48. SSA: Morbilidad y mortalidad por cirrosis hepática. In Salud: México 2006. México, D.F.: Secretaría de Salud; 2007:46-48.
8.
go back to reference Chiquete E, Panduro A: Low prevalence of anti-hepatitis C virus antibodies in Mexico: A systematic review. Intervirology 2007, 50: 1-8. 10.1159/000096306PubMedCrossRef Chiquete E, Panduro A: Low prevalence of anti-hepatitis C virus antibodies in Mexico: A systematic review. Intervirology 2007, 50: 1-8. 10.1159/000096306PubMedCrossRef
9.
go back to reference Lopez RA, Romero-Estrella S, Infante-Ramirez L, Mendez-Aquino JS, Berron-Ruiz P, Morales-Alfaro NA, Vivar R, Carrada E, Rivera-Rendon Mdel R, Sanchez-Guerrero SA: Hepatitis C seroprevalence in accepted versus deferred blood-donor candidates evaluated by medical history and self-exclusion form. Transfusion 2004, 44: 1344-1349. 10.1111/j.1537-2995.2004.03379.xPubMedCrossRef Lopez RA, Romero-Estrella S, Infante-Ramirez L, Mendez-Aquino JS, Berron-Ruiz P, Morales-Alfaro NA, Vivar R, Carrada E, Rivera-Rendon Mdel R, Sanchez-Guerrero SA: Hepatitis C seroprevalence in accepted versus deferred blood-donor candidates evaluated by medical history and self-exclusion form. Transfusion 2004, 44: 1344-1349. 10.1111/j.1537-2995.2004.03379.xPubMedCrossRef
10.
go back to reference Rodriguez-Perez F, Suarez-Perez E, Alvarez-Rohena M, Toro DH: Prevalence of chronic hepatitis C virus genotypes among patients between 21 to 65 years old in Puerto Rico. P R Health Sci J 2004, 23: 49-56.PubMed Rodriguez-Perez F, Suarez-Perez E, Alvarez-Rohena M, Toro DH: Prevalence of chronic hepatitis C virus genotypes among patients between 21 to 65 years old in Puerto Rico. P R Health Sci J 2004, 23: 49-56.PubMed
11.
go back to reference Thakral B, Marwaha N, Chawla YK, Saluja K, Sharma A, Sharma RR, Minz RW, Agnihotri SK: Prevalence & significance of hepatitis C virus (HCV) seropositivity in blood donors. Indian J Med Res 2006, 124: 431-438.PubMed Thakral B, Marwaha N, Chawla YK, Saluja K, Sharma A, Sharma RR, Minz RW, Agnihotri SK: Prevalence & significance of hepatitis C virus (HCV) seropositivity in blood donors. Indian J Med Res 2006, 124: 431-438.PubMed
12.
go back to reference Rivas-Estilla AM, Cordero-Perez P, Trujillo-Murillo Kdel C, Ramos-Jimenez J, Chen-Lopez C, Garza-Rodriguez Mde L, Ramirez-Gutierrez A, Munoz-Espinosa L: Genotyping of hepatitis C virus (HCV) in infected patients from Northeast Mexico. Ann Hepatol 2008, 7: 144-147.PubMed Rivas-Estilla AM, Cordero-Perez P, Trujillo-Murillo Kdel C, Ramos-Jimenez J, Chen-Lopez C, Garza-Rodriguez Mde L, Ramirez-Gutierrez A, Munoz-Espinosa L: Genotyping of hepatitis C virus (HCV) in infected patients from Northeast Mexico. Ann Hepatol 2008, 7: 144-147.PubMed
13.
go back to reference Gongora-Biachi RA, Castro-Sansores CJ, Gonzalez-Martinez P, Lara-Perera DM, Garrido-Palma J, Lara-Perera V: Frequency of antibodies against the hepatitis C virus in patients with hepatic cirrhosis in Yucatan, Mexico. Salud Publica Mex 2003, 45: 346-350.PubMedCrossRef Gongora-Biachi RA, Castro-Sansores CJ, Gonzalez-Martinez P, Lara-Perera DM, Garrido-Palma J, Lara-Perera V: Frequency of antibodies against the hepatitis C virus in patients with hepatic cirrhosis in Yucatan, Mexico. Salud Publica Mex 2003, 45: 346-350.PubMedCrossRef
14.
go back to reference Alter MJ, Kuhnert WL, Finelli L: Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention. MMWR Recomm Rep 2003, 52: 1-13. 15; quiz CE11-14PubMed Alter MJ, Kuhnert WL, Finelli L: Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention. MMWR Recomm Rep 2003, 52: 1-13. 15; quiz CE11-14PubMed
15.
go back to reference Goncales NS, Costa FF, Vassallo J, Goncales FL Jr: Diagnosis of hepatitis C virus in Brazilian blood donors using a reverse transcriptase nested polymerase chain reaction: comparison with enzyme immunoassay and recombinant protein immunoblot assay. Rev Inst Med Trop Sao Paulo 2000, 42: 263-267.PubMed Goncales NS, Costa FF, Vassallo J, Goncales FL Jr: Diagnosis of hepatitis C virus in Brazilian blood donors using a reverse transcriptase nested polymerase chain reaction: comparison with enzyme immunoassay and recombinant protein immunoblot assay. Rev Inst Med Trop Sao Paulo 2000, 42: 263-267.PubMed
16.
go back to reference Dufour DR, Talastas M, Fernandez MD, Harris B, Strader DB, Seeff LB: Low-positive anti-hepatitis C virus enzyme immunoassay results: an important predictor of low likelihood of hepatitis C infection. Clin Chem 2003, 49: 479-486. 10.1373/49.3.479PubMedCrossRef Dufour DR, Talastas M, Fernandez MD, Harris B, Strader DB, Seeff LB: Low-positive anti-hepatitis C virus enzyme immunoassay results: an important predictor of low likelihood of hepatitis C infection. Clin Chem 2003, 49: 479-486. 10.1373/49.3.479PubMedCrossRef
17.
go back to reference Ren FR, Lv QS, Zhuang H, Li JJ, Gong XY, Gao GJ, Liu CL, Wang JX, Yao FZ, Zheng YR, et al.: Significance of the signal-to-cutoff ratios of anti-hepatitis C virus enzyme immunoassays in screening of Chinese blood donors. Transfusion 2005, 45: 1816-1822. 10.1111/j.1537-2995.2005.00611.xPubMedCrossRef Ren FR, Lv QS, Zhuang H, Li JJ, Gong XY, Gao GJ, Liu CL, Wang JX, Yao FZ, Zheng YR, et al.: Significance of the signal-to-cutoff ratios of anti-hepatitis C virus enzyme immunoassays in screening of Chinese blood donors. Transfusion 2005, 45: 1816-1822. 10.1111/j.1537-2995.2005.00611.xPubMedCrossRef
18.
go back to reference MacKenzie WR, Davis JP, Peterson DE, Hibbard AJ, Becker G, Zarvan BS: Multiple false-positive serologic tests for HIV, HTLV-1, and hepatitis C following influenza vaccination, 1991. JAMA 1992, 268: 1015-1017. 10.1001/jama.268.8.1015CrossRef MacKenzie WR, Davis JP, Peterson DE, Hibbard AJ, Becker G, Zarvan BS: Multiple false-positive serologic tests for HIV, HTLV-1, and hepatitis C following influenza vaccination, 1991. JAMA 1992, 268: 1015-1017. 10.1001/jama.268.8.1015CrossRef
19.
go back to reference Contreras AM, Tornero-Romo CM, Toribio JG, Celis A, Orozco-Hernandez A, Rivera PK, Mendez C, Hernandez-Lugo MI, Olivares L, Alvarado MA: Very low hepatitis C antibody levels predict false-positive results and avoid supplemental testing. Transfusion 2008, 48: 2540-2548. 10.1111/j.1537-2995.2008.01886.xPubMedCrossRef Contreras AM, Tornero-Romo CM, Toribio JG, Celis A, Orozco-Hernandez A, Rivera PK, Mendez C, Hernandez-Lugo MI, Olivares L, Alvarado MA: Very low hepatitis C antibody levels predict false-positive results and avoid supplemental testing. Transfusion 2008, 48: 2540-2548. 10.1111/j.1537-2995.2008.01886.xPubMedCrossRef
20.
go back to reference Hyland C, Seed CR, Kiely P, Parker S, Cowley N, Bolton W: Follow-up of six blood donors highlights the complementary role and limitations of hepatitis C virus antibody and nucleic acid amplification tests. Vox Sang 2003, 85: 1-8. 10.1046/j.1423-0410.2003.00316.xPubMedCrossRef Hyland C, Seed CR, Kiely P, Parker S, Cowley N, Bolton W: Follow-up of six blood donors highlights the complementary role and limitations of hepatitis C virus antibody and nucleic acid amplification tests. Vox Sang 2003, 85: 1-8. 10.1046/j.1423-0410.2003.00316.xPubMedCrossRef
21.
go back to reference Baba SS, Fagbami AH, Olaleye OD: Antigenic relatedness of selected flaviviruses: study with homologous and heterologous immune mouse ascitic fluids. Rev Inst Med Trop Sao Paulo 1998, 40: 343-349.PubMedCrossRef Baba SS, Fagbami AH, Olaleye OD: Antigenic relatedness of selected flaviviruses: study with homologous and heterologous immune mouse ascitic fluids. Rev Inst Med Trop Sao Paulo 1998, 40: 343-349.PubMedCrossRef
22.
go back to reference Hennig H, Schlenke P, Kirchner H, Bauer I, Schulte-Kellinghaus B, Bludau H: Evaluation of newly developed microparticle enzyme immunoassays for the detection of HCV antibodies. J Virol Methods 2000, 84: 181-190. 10.1016/S0166-0934(99)00146-9PubMedCrossRef Hennig H, Schlenke P, Kirchner H, Bauer I, Schulte-Kellinghaus B, Bludau H: Evaluation of newly developed microparticle enzyme immunoassays for the detection of HCV antibodies. J Virol Methods 2000, 84: 181-190. 10.1016/S0166-0934(99)00146-9PubMedCrossRef
23.
go back to reference Garson JA, Tedder RS, Briggs M, Tuke P, Glazebrook JA, Trute A, Parker D, Barbara JA, Contreras M, Aloysius S: Detection of hepatitis C viral sequences in blood donations by "nested" polymerase chain reaction and prediction of infectivity. Lancet 1990, 335: 1419-1422. 10.1016/0140-6736(90)91446-HPubMedCrossRef Garson JA, Tedder RS, Briggs M, Tuke P, Glazebrook JA, Trute A, Parker D, Barbara JA, Contreras M, Aloysius S: Detection of hepatitis C viral sequences in blood donations by "nested" polymerase chain reaction and prediction of infectivity. Lancet 1990, 335: 1419-1422. 10.1016/0140-6736(90)91446-HPubMedCrossRef
24.
go back to reference Okamoto H, Kanai N, Mishiro S: Full-length nucleotide sequence of a Japanese hepatitis C virus isolate (HC-J1) with high homology to USA isolates. Nucleic Acids Res 1992, 20: 6410. 10.1093/nar/20.23.6410PubMedPubMedCentralCrossRef Okamoto H, Kanai N, Mishiro S: Full-length nucleotide sequence of a Japanese hepatitis C virus isolate (HC-J1) with high homology to USA isolates. Nucleic Acids Res 1992, 20: 6410. 10.1093/nar/20.23.6410PubMedPubMedCentralCrossRef
25.
go back to reference Davidson F, Simmonds P, Ferguson JC, Jarvis LM, Dow BC, Follett EA, Seed CR, Krusius T, Lin C, Medgyesi GA, et al.: Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5' non-coding region. J Gen Virol 1995,76(Pt 5):1197-1204. 10.1099/0022-1317-76-5-1197PubMedCrossRef Davidson F, Simmonds P, Ferguson JC, Jarvis LM, Dow BC, Follett EA, Seed CR, Krusius T, Lin C, Medgyesi GA, et al.: Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5' non-coding region. J Gen Virol 1995,76(Pt 5):1197-1204. 10.1099/0022-1317-76-5-1197PubMedCrossRef
Metadata
Title
Hepatitis C virus infection in blood donors from the state of Puebla, Mexico
Authors
Francisca Sosa-Jurado
Gerardo Santos-López
Belinda Guzmán-Flores
Julia I Ruiz-Conde
Daniel Meléndez-Mena
Martín T Vargas-Maldonado
Ygnacio Martínez-Laguna
Laura Contreras-Mioni
Verónica Vallejo-Ruiz
Julio Reyes-Leyva
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2010
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-7-18

Other articles of this Issue 1/2010

Virology Journal 1/2010 Go to the issue